Participants
migraine, obesity, CM
INFECTIOUS DISEASES, OBESITY, HEADACHE DISORDERS, HYPERCHOLESTEROLEMIA, SYSTEMIC DISEASE, CORONARY DISEASE, DIABETES MELLITUS, MIGRAINE, HIGH BLOOD PRESSURE
This study was approved by the local Institutional Review Board, and written informed consents were obtained from all participants. From September 2021 to January 2023, individuals diagnosed with EM or CM according to the International Classification of Headache Disorders, 3rd edition criteria were selected.Patients were recruited based on the following inclusion criteria: (1) age: 18–70 years; (2) confirmed diagnosis is EM or CM; (3) history of migraine greater than 1 year. Subjects were excluded if they were (1) high blood pressure; (2) coronary disease; (3) diabetes mellitus; (4) hypercholesterolemia; (5) infectious diseases; (6) chronic inflammatory conditions and other autoimmune conditions; (7) severe systemic diseases; (8) pregnancy or lactation; (9) obesity (body mass index > 30 kg/m